Build Boardroom Capability: Scaling for Start-Ups
Date Wednesday, 29 August 2018
Time 29 Aug 15:30 - 29 Aug 20:00
Venue Aon Australia Level 51 80 Collins Street Melbourne VIC 3000 Australia
Note Prices below are early bird prices. These prices will end on 31 Jul 23:59
Pricing Subscribed Member
$ 140 Per Subscribed Member
Corporate Member
$ 110 Per Corporate Member
Global Member
$ 140 Per Global Member
$ 195 Per Member
$ 140 Per Champion
Guests Allowed
Register by Tuesday, 28 August 2018

Women on Boards invites members and their guests to register for a special event on Wednesday 29 August to introduce angel investing and Scale Investors as an avenue for WOB members (particularly those in the Innovation marketplace) to know more about;

  • the benefits of angel investing and supporting female founded companies, and
  • serving on the boards and advisory boards of early stage companies. 

Scale Investors is a network of angel investors, who connect with, invest in and mentor female, early stage entrepreneurs and start-ups with gender balanced leadership. Since launching in 2013, its community of over 100 HNW women and men has collectively invested $6.1m in 13 female led businesses.

The program is divided into two sessions:

  • Session One (4-6pm): Setting the scene with Scale Chair, Susan Oliver, on the how and why of investing in a Scale company and the expectations of board members in Scale companies, then three female founders will share their experiences followed by a panel discussion.
  • Session Two  (6:30 - 7:30pm): Table based discussions led by Scale board members and other Non-Executive-Directors of early stage companies. 

In parternership with: 



About the Presenters

Susan Oliver, Founding Chairman, Scale

Susan is an experienced chairman and company director serving on the boards of major Australian listed companies. Her current appointments are Director of CNPR, Independent member of the Investment Committee for IFM investors, and on the board of the Melbourne Theatre Company. She is an entrepreneur and co-investor in two software systems. Susan has extensive experience in technology commercialisation, policy development and strategy consulting. She has contributed significantly to the innovation, IT and arts policy agendas in Australia and was awarded a Centenary Medal in 2001 for service to Australian society in Business.

Annette King, Galileo Platforms

Annette is a qualified actuary who co-founded Galileo Platforms Limited, a technology start-up enabling the insurance ecosytem for Asia's digital generation via blockchain technology. Her previous career spanned 26 years’ in life insurance and wealth management, including roles as CEO, Chief Marketing & Strategy Officer and CFO. Annette is an experienced non-executive-director, serving the boards of the Actuaries Institute Australia and the FNZ Group (APAC), a global digital services company that partners with major financial institutions to enable them to provide multi-channel wealth management services to their clients across direct, intermediated and workplace channels.

Eleanor Toulmin, MimicTec

CEO and co-founder of MimicTec, an AgTech startup looking at improving the productivity of poultry farming and life of chickens. Eleanor worked as a strategy and technology consultant at IBM and KPMG, as well as Director of Finance for The Oaktree Foundation. She returned to study in 2016 at the Wade Institute to pursue a Masters of Entrepreneurship, where she met CTO and co-founder Sarah Last, enabling her to pursue her passion about making a disproportionate difference to Australian farmers and livestock through entrepreneurship and innovation. Eleanor also serves on the board for the Foster Care Association of Victoria.

Dr Anabela Correia, LiVac

Anabela is CEO of LiVac, an Australian medical device development company established in 2010, with specific products for use in laproscopic surgery. She has more than 10 years experience in technology commercialisation in the field of medicine and has a PhD in Medicine from Monash University. Currently running her own technology commercialisation business, Anabela's expertise includes successful management of biotechnology companies, management of technologies from early stage development through to global commercialisation, capital sourcing from government and private sectors, grant writing, strategic management of intellectual property & technology portfolios, global technology licensing, spin out company formation and management.

With thanks to our corporate event host: